Paclitaxel + Carboplatin With/ut BMS-275291 in Advanced or Metastatic Non-small Cell Lung Cancer

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

774

Participants

Timeline

Start Date

April 4, 2000

Primary Completion Date

December 10, 2003

Study Completion Date

February 10, 2009

Conditions
Lung Cancer
Interventions
DRUG

carboplatin

DRUG

paclitaxel

DRUG

rebimastat

Trial Locations (69)

2610

Algemeen Ziekenhuis Sint-Augustinus, Wilrijk

4000

Centre Hospitalier Regional de la Citadelle, Liege (Luik)

5001

Kantonspital Aarau, Aarau

20089

Istituto Clinico Humanitas, Rozzano (MI)

25030

CHR de Besancon - Hopital Jean Minjoz, Besançon

27710

Duke University Medical Center, Durham

28041

Hospital Universitario 12 de Octubre, Madrid

30122

Ospedale Civile San Giovanni e Paolo, Venezia

31052

Institut Claudius Regaud, Toulouse

31201

Central Georgia Hematology Oncology, P.C., Macon

37044

Centre Hospitalier Universitaire Bretonneau de Tours, Tours

37205

Saint Thomas Hospital, Nashville

37403

Erlanger Health Systems, Chattanooga

37404

Memorial Hospital Cancer Center - Chattanooga, Chattanooga

37901

Baptist Regional Cancer Center - Knoxville, Knoxville

38043

CHR de Grenoble - La Tronche, Grenoble

38301

Jackson-Madison County General Hospital, Jackson

39008

Hospital Universitario Marques de Valdecilla, Santander

44805

CRLCC Nantes - Atlantique, Nantes-Saint Herblain

46017

Servicio De Oncologia, Valencia

61801

Carle Cancer Center, Urbana

67091

Hopital de Neuhof, Strasbourg

72205

University of Arkansas for Medical Sciences, Little Rock

73190

University of Oklahoma Health Sciences Center, Oklahoma City

92037

Scripps Clinic, La Jolla

93009

Hopital Avicenne, Bobigny

96813

Queen's Medical Center, Honolulu

35294-3300

University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham

01805

Lahey Clinic - Burlington, Burlington

68131-2197

Creighton University Cancer Center, Omaha

37068-1600

Williamson Medical Center, Franklin

37208-3599

Meharry Medical College, Nashville

37232-5536

Division of Medical Oncology - Vanderbilt, Nashville

A-1090

AKH Vienna, Vienna (Wien)

Allgemeines Krankenhaus der Stadt Wien, Vienna (Wien)

B-9000

Universiteit Gent, Ghent

T6G 1Z2

Cross Cancer Institute, Edmonton

R3E 0V9

CancerCare Manitoba, Winnipeg

B3H 1V7

Nova Scotia Cancer Centre, Halifax

L4M 6M2

Royal Victoria Hospital, Barrie, Barrie

L8V 5C2

Cancer Care Ontario-Hamilton Regional Cancer Centre, Hamilton

K1H 1C4

Ottawa Regional Cancer Centre, Ottawa

K9H 7B6

Peterborough Oncology Clinic, Peterborough

P6B 1Y5

Algoma District Medical Group, Sault Ste. Marie

L2R 5K3

Hotel Dieu Health Sciences Hospital - Niagara, St. Catharines

M4N 3M5

Toronto Sunnybrook Regional Cancer Centre, Toronto

M5G 1X5

Mount Sinai Hospital - Toronto, Toronto

M5G 2C4

Toronto General Hospital, Toronto

M6R 1B5

Saint Joseph's Health Centre - Toronto, Toronto

M9N 1N8

Humber River Regional Hospital, Weston

N8W 2X3

Cancer Care Ontario - Windsor Regional Cancer Centre, Windsor

S4T 7T1

Allan Blair Cancer Centre, Regina

S7N 4H4

Saskatoon Cancer Centre, Saskatoon

FIN-0-0029

Helsinki University Central Hospital, Helsinki

06120

Stadisches Krankenhaus Martha Maria Halle-Dolau, Halle

DOH-2-1075

Allgemeines Krankenhaus, Hamburg

D-58675

Lungenklinik Hemer, Hemer

DOH-4-4625

Marienhospital/Ruhr University Bochum, Herne

D-81675

Klinikum Rechts Der Isar/Technische Universitaet Muenchen, Munich (Muenchen)

06122

Oncologia Medica - Perugia, Perugia

00135

Ospedale San Filippo Neri, Rome

00149

Ospedale Carlo Forlanini, Rome

6202 AZ

Academisch Ziekenhuis Maastricht, Maastricht

80-211

Medical University of Gdansk, Gdansk

4434-502

Centro Hospitalar de Vila Nova de Gaia, Vila Nova de Gaia

CH-3010

Inselspital, Bern, Bern

CH-8091

Universitaetsspital, Zurich

W6 8RF

Charing Cross Hospital, London

SW10 9NH

Chelsea Westminster Hospital, London

Sponsors
All Listed Sponsors
lead

NCIC Clinical Trials Group

NETWORK